BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32889748)

  • 21. The effect of adiponectin in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) and the potential role of polyphenols in the modulation of adiponectin signaling.
    Shabalala SC; Dludla PV; Mabasa L; Kappo AP; Basson AK; Pheiffer C; Johnson R
    Biomed Pharmacother; 2020 Nov; 131():110785. PubMed ID: 33152943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prolactin improves hepatic steatosis via CD36 pathway.
    Zhang P; Ge Z; Wang H; Feng W; Sun X; Chu X; Jiang C; Wang Y; Zhu D; Bi Y
    J Hepatol; 2018 Jun; 68(6):1247-1255. PubMed ID: 29452209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Taurine attenuates the development of hepatic steatosis through the inhibition of oxidative stress in a model of nonalcoholic fatty liver disease in vivo and in vitro.
    Murakami S; Ono A; Kawasaki A; Takenaga T; Ito T
    Amino Acids; 2018 Sep; 50(9):1279-1288. PubMed ID: 29946793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A model of hepatic steatosis with declined viability and function in a liver-organ-on-a-chip.
    Wiriyakulsit N; Keawsomnuk P; Thongin S; Ketsawatsomkron P; Muta K
    Sci Rep; 2023 Oct; 13(1):17019. PubMed ID: 37813918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans.
    Bai J; Xia M; Xue Y; Ma F; Cui A; Sun Y; Han Y; Xu X; Zhang F; Hu Z; Liu Z; Liu Y; Cai G; Su W; Sun X; Wu H; Yan H; Chang X; Hu X; Bian H; Xia P; Gao J; Li Y; Gao X
    EBioMedicine; 2020 Jul; 57():102849. PubMed ID: 32580141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quercetin improves nonalcoholic fatty liver by ameliorating inflammation, oxidative stress, and lipid metabolism in db/db mice.
    Yang H; Yang T; Heng C; Zhou Y; Jiang Z; Qian X; Du L; Mao S; Yin X; Lu Q
    Phytother Res; 2019 Dec; 33(12):3140-3152. PubMed ID: 31452288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dietary Polyphenols Protect Against Oleic Acid-Induced Steatosis in an in Vitro Model of NAFLD by Modulating Lipid Metabolism and Improving Mitochondrial Function.
    Rafiei H; Omidian K; Bandy B
    Nutrients; 2019 Mar; 11(3):. PubMed ID: 30832407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isoquercetin Improves Hepatic Lipid Accumulation by Activating AMPK Pathway and Suppressing TGF-β Signaling on an HFD-Induced Nonalcoholic Fatty Liver Disease Rat Model.
    Qin G; Ma J; Huang Q; Yin H; Han J; Li M; Deng Y; Wang B; Hassan W; Shang J
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30572631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quercetin ameliorates dysregulation of lipid metabolism genes via the PI3K/AKT pathway in a diet-induced mouse model of nonalcoholic fatty liver disease.
    Pisonero-Vaquero S; Martínez-Ferreras Á; García-Mediavilla MV; Martínez-Flórez S; Fernández A; Benet M; Olcoz JL; Jover R; González-Gallego J; Sánchez-Campos S
    Mol Nutr Food Res; 2015 May; 59(5):879-93. PubMed ID: 25712622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mesencephalic astrocyte-derived neurotrophic factor ameliorates steatosis in HepG2 cells by regulating hepatic lipid metabolism.
    He M; Wang C; Long XH; Peng JJ; Liu DF; Yang GY; Jensen MD; Zhang LL
    World J Gastroenterol; 2020 Mar; 26(10):1029-1041. PubMed ID: 32205994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Water Extract of Dolichos lablab Attenuates Hepatic Lipid Accumulation in a Cellular Nonalcoholic Fatty Liver Disease Model.
    Im AR; Kim YH; Lee HW; Song KH
    J Med Food; 2016 May; 19(5):495-503. PubMed ID: 27152979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The p66shc-mediated Regulation of Hepatocyte Senescence Influences Hepatic Steatosis in Nonalcoholic Fatty Liver Disease.
    Zhang J; Li Y; Wang B; Luo Y; Shi J; Zhao B
    Med Sci Monit; 2020 Mar; 26():e921887. PubMed ID: 32191680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antioxidant activity of Hydroxytyrosol and Vitamin E reduces systemic inflammation in children with paediatric NAFLD.
    Mosca A; Crudele A; Smeriglio A; Braghini MR; Panera N; Comparcola D; Alterio A; Sartorelli MR; Tozzi G; Raponi M; Trombetta D; Alisi A
    Dig Liver Dis; 2021 Sep; 53(9):1154-1158. PubMed ID: 33060043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Takahashi Y; Sugimoto K; Inui H; Fukusato T
    World J Gastroenterol; 2015 Apr; 21(13):3777-85. PubMed ID: 25852263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway.
    Zhang J; Du H; Shen M; Zhao Z; Ye X
    J Immunol Res; 2020; 2020():3413186. PubMed ID: 32884949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation effects of total flavonoids in Morus alba L. on hepatic cholesterol disorders in orotic acid induced NAFLD rats.
    Hu Y; Xu J; Chen Q; Liu M; Wang S; Yu H; Zhang Y; Wang T
    BMC Complement Med Ther; 2020 Aug; 20(1):257. PubMed ID: 32807146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of resveratrol and other polyphenols in hepatic steatosis.
    Aguirre L; Portillo MP; Hijona E; Bujanda L
    World J Gastroenterol; 2014 Jun; 20(23):7366-80. PubMed ID: 24966607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hydroxytyrosol prevents reduction in liver activity of Δ-5 and Δ-6 desaturases, oxidative stress, and depletion in long chain polyunsaturated fatty acid content in different tissues of high-fat diet fed mice.
    Valenzuela R; Echeverria F; Ortiz M; Rincón-Cervera MÁ; Espinosa A; Hernandez-Rodas MC; Illesca P; Valenzuela A; Videla LA
    Lipids Health Dis; 2017 Apr; 16(1):64. PubMed ID: 28395666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatoprotective Effect of Seed Coat ofEuryale ferox Extract in Non-alcoholic Fatty Liver Disease Induced by High-fat Diet in Mice by Increasing IRs-1 and Inhibiting CYP2E1.
    Jian T; Yu C; Ding X; Chen J; Li J; Zuo Y; Ren B; Lv H; Li W
    J Oleo Sci; 2019 Jun; 68(6):581-589. PubMed ID: 31092797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gut-liver on a chip toward an in vitro model of hepatic steatosis.
    Lee SY; Sung JH
    Biotechnol Bioeng; 2018 Nov; 115(11):2817-2827. PubMed ID: 29981260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.